Birla Corporation DuPont analysis

Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
0.74×0.73×0.78×0.73×0.94×
0.82×0.83×0.59×0.67×0.16×
9.2%9.6%7.0%8.9%3.0%
0.67×0.67×0.64×0.68×0.62×
1.97×1.97×2.04×2.16×2.35×
7.4%7.6%4.2%6.4%0.7%
7.8%7.8%4.3%6.7%0.7%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

BIRLACORPN₹790.00

Birla Corporation Ltd.

· Infrastructure
₹ CrorePeersJKCEMENTPRSMJOHNSNJKLAKSHMIORIENTCEMSTARCEMENTNUVOCOINDIACEMRAMCOCEMMcap ₹6,084 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×0.940.730.780.730.74
Interest Burden (Pretax/EBIT) ×0.160.670.590.830.82
EBIT Margin %3.028.897.009.569.20
Asset Turnover ×0.620.680.640.670.67
Financial Leverage (Assets/Equity) ×2.352.162.041.971.97
ROE (5-step product, year-end total equity) %0.686.404.197.627.42
ROE (owners' profit / average owners' equity) %0.676.654.317.767.76
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.